GERON CORP - 10-Q Filing

Geron Corp reports third quarter 2026 financial results including revenue components and debt obligations under the Pharmakon Loan Agreement.

SEC EDGAR ·

Tickers: $GERN

Read the full article at SEC EDGAR

More Regulatory news